The Upstream Advantage: Unlocking bioprocessing potential
3:26
Hear from Thermo Fisher Scientific colleagues and learn about their perspectives on the future of bioprocessing.
Related Videos
In What's new
-
Play video India’s Biopharma Future: Insights from Biological E & BDC
India’s Biopharma Future: Insights from Biological E & BDC
Explore India’s evolving biologics and biosimilars landscape in this Bioprocess Design Center interview with Biological E. Topics include platform technologies, regulatory readiness, scale-up, innovation, and collaboration opportunities.
17:22
-
Play video Peptones in Vaccine Manufacturing: Boosting Yield & Efficiency
Peptones in Vaccine Manufacturing: Boosting Yield & Efficiency
Discover how peptones improve vaccine manufacturing by enhancing cell growth, viral titers, scalability, and serum reduction. Explore real-world data for HEK293, Vero, and BHK21 workflows in viral vaccine production.
41:46
-
Play video Single-Use Assembly Design with Digital Configurator Demo
Single-Use Assembly Design with Digital Configurator Demo
Learn how digital configurator tools streamline single-use assembly design, improving speed, standardization, and supply chain efficiency in bioprocessing while reducing risk and enabling flexible manufacturing.
44:04
-
Play video Reducing Particulate Batch Risk in Bioprocessing
Reducing Particulate Batch Risk in Bioprocessing
Learn how proactive particulate control strategies help reduce batch risk, investigations, and manufacturing disruptions in bioprocessing.
30:35
-
Play video Single-use bioreactor scaling calculator demo
Single-use bioreactor scaling calculator demo
Learn how to use a single-use bioreactor scale-up calculator to simplify complex bioprocess calculations, improve accuracy, and support efficient development and production workflows.
8:35
-
Play video Tame Your Misbehavin’ Molecules: Advanced mAb Purification
Tame Your Misbehavin’ Molecules: Advanced mAb Purification
Discover advanced chromatography and affinity resin strategies to purify complex monoclonal antibodies, reduce aggregates and impurities, and improve downstream process efficiency.
0:30
